Miltefosine Rescue Treatment for Visceral Leishmaniasis Relapse Patient
We report the first case of miltefosine rescue treatment carried out for visceral leishmaniasis (VL) relapse patient. Despite undergoing treatment regimens of liposomal amphotericin B (LAMB) 5 mg/kg (standard: 10 mg/kg) daily for 3 days during the first episode followed by LAMB 5 mg/kg stat and paro...
Saved in:
Main Authors: | Anup Bastola, Mitesh Shrestha, Bimal Sharma Chalise, Abhdesh Kumar Mishra, Lina Devkota |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2019-01-01
|
Series: | Case Reports in Infectious Diseases |
Online Access: | http://dx.doi.org/10.1155/2019/3634568 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Relapse of Visceral Leishmaniasis in an HIV-Infected Patient Successfully Treated with a Combination of Miltefosine and Amphotericin B
by: Shauna McQuarrie, et al.
Published: (2015-01-01) -
Lingual Leishmaniasis Presenting to Maxillofacial Surgery in UK with Successful Treatment with Miltefosine
by: K. Kassam, et al.
Published: (2013-01-01) -
Use of Oral Miltefosine for Cutaneous Leishmaniasis in Canadian Soldiers Returning from Afghanistan
by: Yoav Keynan, et al.
Published: (2008-01-01) -
Immunity to Visceral Leishmaniasis
by: Nahid Ali, et al.
Published: (2012-01-01) -
Evaluation of the Ability of Miltefosine Associated with Topical GM-CSF in Modulating the Immune Response of Patients with Cutaneous Leishmaniasis
by: Fábio Peixoto, et al.
Published: (2020-01-01)